Literature DB >> 3267143

Choice of comparison group and findings of computerised tomography in schizophrenia.

G N Smith1, W G Iacono, M Moreau, K Tallman, M Beiser, B Flak.   

Abstract

The literature indicates that whether or not schizophrenic patients are reported to have significant lateral ventricular enlargement depends on control, and not schizophrenic-group values. This discrepancy does not result from differences in age, the ratio of males to females, the number of control subjects used in each study, or whether control groups are comprised of normal subjects or medical patients. However, medical-patient controls tend to have smaller ventricles than do normal individuals. Thus, we assessed lateral- and third-ventricle size and the degree of cortical atrophy in 30 normal volunteers, 30 medical patients, and 30 chronic schizophrenic patients. The use of a medical control group seemed to result in underestimates of ventricle and sulcal size in the normal population and, therefore, overestimates of these values in schizophrenic groups.

Entities:  

Mesh:

Year:  1988        PMID: 3267143     DOI: 10.1192/bjp.153.5.667

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

Review 1.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

2.  Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences.

Authors:  A K Malla; J Takhar; R M Norman; L Assis
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

3.  A comprehensive method of assessing routine CT scans in schizophrenia.

Authors:  G N Smith; S W Flynn; L C Kopala; A S Bassett; J S Lapointe; P Falkai; W G Honer
Journal:  Acta Psychiatr Scand       Date:  1997-11       Impact factor: 6.392

4.  Why knowing healthy controls matters.

Authors:  Adriana J Pavletic
Journal:  Int J Clin Pract       Date:  2019-10-14       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.